Effects of HIV-1 and HIV-1 Envelope Glycoproteins on Signaling Pathways in Human T Lymphocytes
HIV-1 infection is unique with regard to immune responses, in which there is evidence for immune paradox, i. e., both immune activation and immune suppression. Immune stimulation is evident by elevated levels of various cytokines and hyperimmunoglobulinemia, whereas immune suppression is associated with quantitative and qualitative deficiency of T cells, especially of CD4+ T cells (reviewed in Fauci, 1988). It appears that HIV-1 or its envelope glycoproteins (gp160, gp120) can induce these paradoxical changes by various mechanisms, including blocking CD4-major histocompatibility complex (MHC) class II interaction and by altering signal transduction pathway. In this chapter, I will review the role of HIV-1 and its glycoproteins in activation and downregulation of signaling pathways in human T cells.
KeywordsTyrosine Cyclosporin Bismuth Triphosphate Transferrin
Unable to display preview. Download preview PDF.
- Chirmule, N., Kalyanaraman, V., Oyaizu, N., and Pahwa, S., 1988, Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses, J. AIDS 1:425–430.Google Scholar
- Jabado, N., LeDeist, F., Fischer, A., and Hivroz, C., 1994, Interaction of HIV gp120 and anti-CD4 antibodies with CD4 molecule on human CD4+ T cells inhibits the binding activity of NFAT, NF-kB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity, Eur. J. Immunol. 24:2646–2652.PubMedCrossRefGoogle Scholar
- Kaufmann, R., Laroche, D., Buchner, K., Hucho, F., Rudd, C., Lindschau, P., Ludwig, A., Hoer, E., Oberdisse, E., Kopp, J., Körner, I. J., and Repke, H., 1992, The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction, J. AIDS 15:760–770.Google Scholar
- Nye, K. E., Riley, G. A., and Pinching, A. J., 1992, The defect seen in the PI hydrolysis pathway in HIV infected lymphocytes and lymphoblastoid cells is due to inhibition of the 1,4,5 triphosphate, 1,3,4,5 tetrakisphosphate and 5-phosphomonoesterase, Clin. Exp. Immunol. 89:89–93.PubMedCrossRefGoogle Scholar
- Oyaizu, N., Chirmule, N., Kalyanaraman, V S., Hall, W. W., Good, R. A., and Pahwa, S., 1990, Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA, Proc. Natl. Acad. Sci. USA 87:2379–2383.PubMedCrossRefGoogle Scholar
- Shalaby, M. R., Krowka, J. R., Gregory, T. J., Hirabayashi, S. E., McCabe, S. M., Kaufman, D. S., Stites, D. P., and Ammann, A. J., 1987, The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro, Cell Immunol. 110:140–148.PubMedCrossRefGoogle Scholar